Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease.
A Randomized, Open-Label, Phase 3 Study to Compare Long-Term Safety and Tolerability of the TAK-491 and Chlorthalidone Fixed-Dose Combination Versus Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination in Hypertensive Subjects With Moderate Renal Impairment
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease.
A Randomized, Open-Label, Phase 3 Study to Compare Long-Term Safety and Tolerability of the TAK-491 and Chlorthalidone Fixed-Dose Combination Versus Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination in Hypertensive Subjects With Moderate Renal Impairment
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease.
A Randomized, Open-Label, Phase 3 Study to Compare Long-Term Safety and Tolerability of the TAK-491 and Chlorthalidone Fixed-Dose Combination Versus Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination in Hypertensive Subjects With Moderate Renal Impairment
Status: Archived
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease.
A Randomized, Open-Label, Phase 3 Study to Compare Long-Term Safety and Tolerability of the TAK-491 and Chlorthalidone Fixed-Dose Combination Versus Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination in Hypertensive Subjects With Moderate Renal Impairment
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Maine Children's Medical Center
mi
from
Portland, ME
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Maine Children's Medical Center
mi
from
Portland, ME
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Brigham and Women's
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Brigham and Women's
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Weill Medical College of Cornell University
mi
from
New York, NY
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Weill Medical College of Cornell University
mi
from
New York, NY
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Rhode Island Hospital
mi
from
Providence, RI
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Rhode Island Hospital
mi
from
Providence, RI
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Inova Fairfax
mi
from
Falls Church, VA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
Randomized Placebo Controlled Trial of Treprostinil Infusion Combined With Oral Tadalafil or Placebo in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Inova Fairfax
mi
from
Falls Church, VA
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Taustine Eye Center
mi
from
Louisville, KY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Taustine Eye Center
mi
from
Louisville, KY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Comprehensive Eye Care
mi
from
St Louis, MO
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Comprehensive Eye Care
mi
from
St Louis, MO
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Rochester Ophthalmology Group
mi
from
Rochester, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Rochester Ophthalmology Group
mi
from
Rochester, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Glaucoma Consultants of the Capital Region
mi
from
Slingerlands, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Glaucoma Consultants of the Capital Region
mi
from
Slingerlands, NY
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
The Eye Institute
mi
from
Tulsa, OK
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
The Eye Institute
mi
from
Tulsa, OK
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Wills Eye Institute
mi
from
Philadelphia, PA
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Wills Eye Institute
mi
from
Philadelphia, PA
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Black Hills Eye Institute
mi
from
Rapid City, SD
AR-12286 in Combination With Latanoprost
A Phase 2, Double-masked, Randomized, Active-controlled, Crossover Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 or Timolol Added to Patients With Elevated Intraocular Pressure Currently Using Latanoprost
Status: Archived
Updated: 1/1/1970
Black Hills Eye Institute
mi
from
Rapid City, SD
Divided Dose of Travatan
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Divided Dose of Travatan
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% Fixed Combination TID vs. Brinzolamide 1% TID or Brimonidine 0.2% TID
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% Fixed Combination TID vs. Brinzolamide 1% TID or Brimonidine 0.2% TID
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination TID vs. Brinzolamide 1% TID and Brimonidine 0.2% TID
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Efficacy and Safety Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination TID vs. Brinzolamide 1% TID and Brimonidine 0.2% TID
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
Hemodynamic Effect of Intrathecal Clonidine in Hypertensive Subjects: A Pilot Study to Assess Its Effectiveness in Hypertensive Subjects With Poor Blood Pressure Control (Phase II)
Status: Archived
The Center for Clinical Research
mi
from
Winston-Salem, NC
Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
Hemodynamic Effect of Intrathecal Clonidine in Hypertensive Subjects: A Pilot Study to Assess Its Effectiveness in Hypertensive Subjects With Poor Blood Pressure Control (Phase II)
Status: Archived
Updated: 1/1/1970
The Center for Clinical Research
mi
from
Winston-Salem, NC
Improving Antihypertensive Medication Adherence
Improving Antihypertensive Medication Adherence
Status: Archived
University of Connecticut Health Center
mi
from
Farmington, CT
Improving Antihypertensive Medication Adherence
Improving Antihypertensive Medication Adherence
Status: Archived
Updated: 1/1/1970
University of Connecticut Health Center
mi
from
Farmington, CT
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
A Phase IV Clinical Trial of Intensified Blood Pressure Management in Primary Care Using Valsartan Alone and as Combination Anti-Hypertensive Therapy
Status: Archived
Novartis Pharmaceuticals
mi
from
East Hanover, NJ
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
A Phase IV Clinical Trial of Intensified Blood Pressure Management in Primary Care Using Valsartan Alone and as Combination Anti-Hypertensive Therapy
Status: Archived
Updated: 1/1/1970
Novartis Pharmaceuticals
mi
from
East Hanover, NJ
Pacific Kids DASH for Health
Pacific Kids DASH for Health
Status: Archived
Kaiser Foundation Hospital
mi
from
Los Angeles, CA
Pacific Kids DASH for Health
Pacific Kids DASH for Health
Status: Archived
Updated: 1/1/1970
Kaiser Foundation Hospital
mi
from
Los Angeles, CA
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
Interstitial Lung Disease and Pulmonary Hypertension Programs
mi
from
New Hyde Park, NY
Biomarkers in the Evaluation of Chronic Lung Disease
Biomarkers in the Evaluation of Chronic Lung Disease
Status: Archived
Updated: 1/1/1970
Interstitial Lung Disease and Pulmonary Hypertension Programs
mi
from
New Hyde Park, NY
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Newark, DE
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Newark, DE
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Kansas City, MO
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, MO
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Camden, NJ
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Camden, NJ
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Philadelphia, PA
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Philadelphia, PA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
St. Francis Hospital
mi
from
Federal Way, WA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
St. Francis Hospital
mi
from
Federal Way, WA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Univeristy of South Florida
mi
from
Tampa, FL
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Univeristy of South Florida
mi
from
Tampa, FL
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Idaho State University
mi
from
Pocatello, ID
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Idaho State University
mi
from
Pocatello, ID
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Genesis Health System
mi
from
Davenport, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Genesis Health System
mi
from
Davenport, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Broadlawns Medical Center
mi
from
Des Moines, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Broadlawns Medical Center
mi
from
Des Moines, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Iowa
mi
from
Iowa City, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Northeast Iowa Medical Education Foundation
mi
from
Waterloo, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Northeast Iowa Medical Education Foundation
mi
from
Waterloo, IA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Cambridge Hospital
mi
from
Cambridge, MA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Cambridge Hospital
mi
from
Cambridge, MA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
SUNY-University of Buffalo
mi
from
Buffalo, NY
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
SUNY-University of Buffalo
mi
from
Buffalo, NY
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
University of Pittsburgh
mi
from
Pittsburgh, PA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Spartanburg Regional Health Service District
mi
from
Spartanburg, SC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Spartanburg Regional Health Service District
mi
from
Spartanburg, SC
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Texas Tech University Health Science Center
mi
from
Amarillo, TX
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Collaborative Model to Improve BP Control and Minimize Racial Disparities-CCC
Status: Archived
Updated: 1/1/1970
Texas Tech University Health Science Center
mi
from
Amarillo, TX